Anti-CD38 Antibodies for Treatment of Acute Lymphoblastic Leukemia
- 专利权人:
- Janssen Biotech; Inc.
- 发明人:
- Parul Doshi
- 申请号:
- US14629965
- 公开号:
- US20150246975A1
- 申请日:
- 2015.02.24
- 申请国别(地区):
- US
- 年份:
- 2015
- 代理人:
- 摘要:
- The present invention relates to combination therapies with anti-CD38 antibodies.
- 来源网站:
- 中国工程科技知识中心
相关发明人
相关专利
- BISPECIFIC ANTI-CD20/ANTI-CD3 ANTIBODIES TO TREAT ACUTE LYMPHOBLASTIC LEUKEMIA
- Anti-CD38 antibody for the treatment of acute lymphoblastic leukemia
- Anti-CD38 Antibodies for Treatment of Acute Lymphoblastic Leukemia
- ANTI-CD38 ANTIBODIES FOR TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA
- ANTI-CD38 ANTIBODIES FOR TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA